Peptide dynamic fingerprints: a tool for investigating the role of conformational flexibility for GLP-1 analogs affinity.
Glucagon-like peptide-1 (GLP-1) is a 30-residue peptide implicated in short-term appetite regulation. Its analogs are presumed to be potential drugs against obesity and non-insulin dependent diabetes mellitus (NIDDM or type 2 diabetes). This study examined how the dynamic fingerprints can be used for establishing dynamics-activity relationships in a series of peptides for which the mechanism of action is unknown and in which mutations can cause an increase or decrease in biological activity. The 3D autocorrelation method was used to generate maps of both active and inactive analogs. As the active conformation of GLP-1 is not yet clearly defined, the dynamic fingerprints of peptides in an aqueous environment were compared to explain the high affinity of the peptide for its receptor. The suggestion that the peptide could bind to the receptor in a folded conformation has been examined. In the case of the GLP-1 analogs, it was shown that the folding tendency cannot be directly related to affinity values and the results do not favor a folded active conformation model of GLP-1.
Adenot
M
M
Centre de Biochimie Structurale, Montpellier, France. madenot@syntem.com
de Menthière
C Sarrauste
CS
Kervran
A
A
Grassy
G
G
D000818:Animals; D002460:Cell Line; D005934:Glucagon / Q000031:analogs & derivatives; D000067757:Glucagon-Like Peptide-1 Receptor; D057927:Hydrophobic and Hydrophilic Interactions; D010449:Peptide Mapping / Q000145:classification; D011487:Protein Conformation; D018027:Receptors, Glucagon / Q000378:metabolism
D000067757:Glucagon-Like Peptide-1 Receptor; D018027:Receptors, Glucagon; D005934:Glucagon